SCHEMBL22839795

SCHEMBL22839795

CNc1c(O)ccc(CCN(Cc2c(F)cc(C(=O)O)cc2OC)C(=O)OC(C)(C)C)c1/C=C\C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22839884 0.89 HTT (0.35) —
SCHEMBL22839890 0.86 PTGDR2 (0.31) —
SCHEMBL22839935 0.83 PPARG (0.36) —
SCHEMBL22839829 0.83 TSHR (0.32) —
SCHEMBL22839937 0.82 NAMPT (0.33) —
SCHEMBL22839880 0.82 — —
SCHEMBL22839942 0.82 EPHX2 (0.33) —
SCHEMBL22839885 0.82 P4HB (0.32) —
SCHEMBL22839824 0.82 HDAC1 (0.39) —
SCHEMBL22839818 0.82 EPHX2 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3484879-B1 HYDROXYQUINOLINONE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARM SPA (IT) 2020-12-30 — — EP disclosed
Send feedback